NAD+, NMN, and NR are three of the most-marketed compounds in the longevity space. They are also commonly conflated. They are different molecules with different routes of administration, different bioavailability profiles, different regulatory statuses, and different evidence bases.
This post is the practical comparison framework — what each compound actually is, what the evidence shows, and what clinically grounded use looks like in 2026.
What NAD+ does in the body
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, central to:
- Mitochondrial energy production. NAD+ shuttles electrons through the electron transport chain to produce ATP.
- DNA repair. NAD+ is required for PARP enzymes that repair DNA damage.
- Sirtuin signaling. NAD+ activates the sirtuin pathway, which regulates gene expression involved in metabolism, inflammation, and aging.
- Cellular redox balance. NAD+ moves between oxidized (NAD+) and reduced (NADH) forms across many metabolic reactions.
Tissue NAD+ levels decline with age. The decline correlates with metabolic dysfunction, reduced mitochondrial function, and various aging-related changes. The hypothesis behind raising NAD+ levels: if low NAD+ is part of why aging happens, raising NAD+ might slow some aging processes. This is plausible mechanistically. Whether it produces clinical benefit at the magnitude marketing suggests is much less clear.
For more on what NAD+ does specifically, see our NAD+ cellular aging and sirtuin pathway post.
The four main approaches
1. Direct NAD+ injection (subcutaneous or IV)
What it is: Pharmaceutical-grade NAD+ administered by injection (subcutaneous self-administration at home, or IV in a clinic setting).
Route: Subcutaneous most common for self-administered prescribed protocols; IV for clinic-administered higher doses.
Bioavailability: Very high. Injectable NAD+ bypasses gastric absorption entirely and reaches circulation directly.
Dose: Typical prescribed protocols range from 100mg-300mg per dose, frequency varies by indication (daily, every-other-day, weekly).
Evidence: The strongest mechanistic evidence — injectable NAD+ measurably raises tissue NAD+ levels in human studies. Clinical-outcome evidence is mixed depending on the population studied.
Regulatory: NAD+ has a USP monograph and is legitimately compounded by 503A pharmacies. Prescribed and dispensed by licensed clinician + licensed pharmacy.
Cost: Through direct-pay telehealth, $99-$300/month for typical home-injection protocols. Clinic IV sessions range $300-$800 per session.
Practical fit: Highest-clinical-signal option. Suitable for patients seeking the strongest possible NAD+ elevation with clinical oversight. Covered in detail in NAD+ at-home self-administered protocols.
2. Oral NMN (nicotinamide mononucleotide)
What it is: A direct precursor to NAD+, one metabolic step away from NAD+ itself.
Route: Oral capsule or sublingual.
Bioavailability: Limited. NMN appears to be partially broken down to nicotinamide in the gut before absorption, then converted back to NMN in tissues. The net NAD+ elevation from oral NMN is meaningful but smaller than from injectable NAD+.
Dose: Typical doses 250-1000mg daily.
Evidence: Small human studies show measurable but modest increases in blood NAD+ levels. Functional endpoint studies have produced mixed results — some signals on insulin sensitivity, exercise capacity, sleep quality; many null findings.
Regulatory status (2022-2026): Complicated. NMN was sold widely as a dietary supplement until November 2022, when FDA notified manufacturers that NMN had been the subject of an investigational new drug (IND) application and was therefore reclassified as a drug, not a supplement. The status remains contested as of 2026 — some manufacturers continue to sell NMN as a supplement; FDA enforcement has been inconsistent. The honest read: NMN is in regulatory limbo. It is widely available but not on solid legal ground as a supplement, and not approved as a drug.
Cost: $30-$80/month for typical supplement doses.
Practical fit: For consumers who want oral convenience and accept the bioavailability and regulatory uncertainty. Not appropriate for patients seeking a clinical-grade intervention.
3. Oral NR (nicotinamide riboside)
What it is: Another NAD+ precursor, two metabolic steps from NAD+.
Route: Oral capsule, most commonly sold as the chloride salt (nicotinamide riboside chloride, branded "Niagen" by ChromaDex).
Bioavailability: Better than NMN through the oral route — NR appears to survive gastric breakdown more reliably and convert to NAD+ in tissues.
Dose: Typical doses 300-600mg daily.
Evidence: Multiple small-to-medium human studies show measurable NAD+ elevation. Clinical-outcome studies have been mixed — modest signals on some markers (insulin sensitivity, blood pressure) and null findings on others. No dramatic anti-aging effects established.
Regulatory status: Sold as a dietary supplement (legal, regulated by DSHEA rules for supplements rather than drug rules). The branded Niagen formulation is the most-studied.
Cost: $30-$80/month for typical supplement doses.
Practical fit: The most-established consumer NAD+ precursor option. Reasonable choice for patients wanting an oral approach with the strongest evidence base among oral options.
4. Niacin and niacinamide (broader B3 family)
What it is: Niacin (nicotinic acid) and niacinamide (nicotinamide) are simpler B-vitamin forms that also serve as NAD+ precursors.
Route: Oral.
Bioavailability: Good but the conversion path is longer (more metabolic steps to reach NAD+).
Evidence: Strong evidence base for traditional uses (lipid management for niacin; broader B-vitamin nutrition for both). Specific NAD+-elevation evidence is more limited; the conversion is slower and partial.
Cost: Very low. $5-$15/month for typical doses.
Practical fit: Adequate for general B-vitamin sufficiency; not the primary NAD+-elevation strategy in modern protocols.
Side-by-side comparison
| Property | Injectable NAD+ | Oral NMN | Oral NR | Niacinamide |
|---|---|---|---|---|
| Bioavailability | Very high | Limited | Better than NMN | Good |
| NAD+ elevation magnitude | Strongest | Modest | Moderate | Smallest |
| Regulatory status | USP monograph; 503A compoundable | Contested (supplement vs drug) | Supplement (DSHEA) | Supplement |
| Cost / month | $99-300 (telehealth) | $30-80 | $30-80 | $5-15 |
| Clinical oversight | Yes, prescribed | No | No | No |
| Evidence strength | Strongest mechanistic | Mixed | Mixed | Limited NAD+-specific |
| Convenience | Self-injection | Oral capsule | Oral capsule | Oral capsule |
The clinical question
The honest framing: NAD+ supplementation is one of the more promising and one of the more overmarketed areas of longevity intervention.
The mechanism is real. NAD+ levels do decline with age. NAD+ is centrally involved in mitochondrial function, DNA repair, and sirtuin signaling. Raising NAD+ levels does produce measurable biological effects.
The clinical translation is uneven. The studies that have looked at functional endpoints — exercise capacity, cognitive function, insulin sensitivity, sleep quality — have produced modest, mixed, and sometimes null results. The dramatic anti-aging claims that animate the marketing have not been demonstrated in humans.
The honest patient framing:
- If you have specific clinical context (chronic fatigue, post-acute recovery, mild metabolic dysfunction), injectable NAD+ through a prescribed protocol may have a useful role. The clinical signal is largest in patients with measurable baseline dysfunction.
- If you are a healthy adult under 50 with no specific complaint, the evidence does not support strong recommendation. Diet, sleep, exercise, and stress management probably produce more measurable benefit per dollar.
- If you want to try oral precursors for general "longevity insurance," NR has the most-established evidence base. Expect modest, not dramatic, effects.
For more on the clinical context where prescribed NAD+ makes most sense, see who NAD+ therapy is for.
What patients should not do
Several patterns I have seen:
Substituting NAD+ for the basics. Sleep, exercise, dietary protein, stress management produce more measurable health effects than any NAD+ protocol. NAD+ is an adjunct, not a replacement.
Stacking everything. Some patients take oral NMN, oral NR, injectable NAD+, and a B-complex simultaneously. The additive benefit is unclear; the cost adds up. Pick one approach.
Believing the marketing. The longevity-supplement industry markets NAD+ precursors with claims that substantially exceed the evidence. The studies show modest effects; the marketing implies dramatic effects.
Buying research-grade NAD+ online. Unverified material with no clinical oversight. Use legitimate compounded NAD+ through a licensed pharmacy with a US-licensed prescriber.
TelePeptide's position
TelePeptide offers prescribed injectable NAD+ through 503A compounding pharmacies as part of our cellular-energy / longevity protocols. This is the most-evidenced route, with clinical oversight, dose calibration to individual context, and ongoing prescriber relationship.
We do not sell oral NMN or NR — those are supplements, sold appropriately by supplement retailers, and do not require a clinical prescribing relationship.
The decision tree for patients evaluating NAD+ approaches:
- Do you have specific clinical context (fatigue, recovery, metabolic dysfunction)? Talk to a clinician about prescribed injectable NAD+.
- Are you healthy and curious about general longevity intervention? Oral NR is the most-evidenced option; expect modest effects; the basics (sleep, exercise, protein) likely produce more measurable benefit.
- Are you neither of the above? Save the money and focus on the fundamentals.
Bottom line
NAD+, NMN, and NR are different molecules with different routes, different bioavailability, different regulatory status, and different evidence bases. Injectable NAD+ produces the strongest measurable signal through legitimate prescribed channels. Oral NR has the most-established consumer-supplement evidence base. NMN is in regulatory limbo. For most healthy adults, the basics outpace any NAD+ protocol. For patients with specific clinical context, prescribed NAD+ may have a useful role. Match the intervention to your actual situation, not to the marketing.
FAQ
Common questions
What is the difference between NAD+, NMN, and NR?
NAD+ is the active coenzyme. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors — molecules that the body converts into NAD+ through intracellular enzymes. NAD+ given by injection raises tissue NAD+ levels directly. NMN and NR taken orally raise NAD+ through the precursor pathway, with lower bioavailability but easier administration.
Which is better — direct NAD+ injection or oral precursors?
For raising NAD+ levels measurably and quickly, direct subcutaneous NAD+ injection produces the strongest signal. For convenience and lower cost, oral NMN or NR are easier but produce smaller NAD+ elevations. The clinical question is whether the magnitude of NAD+ elevation matters for the desired effect — and for most longevity-positioned uses, the answer is unclear.
Is oral NMN or NR effective?
Both raise blood NAD+ levels modestly in humans. Both have been studied in small clinical trials with mixed results on functional endpoints. Neither has produced the dramatic anti-aging effects that marketing materials suggest. They are likely safe at studied doses; they may produce subtle benefits; the evidence does not support strong efficacy claims.
What is the regulatory status of NAD+, NMN, and NR?
NAD+ has a USP monograph and can be legitimately compounded by 503A pharmacies as an injectable. NMN was sold as a dietary supplement in the US until 2022, when FDA reclassified it as a drug (not a supplement) following an investigational new drug application. NR is sold as a dietary supplement under the brand name Niagen and similar formulations.
Are there safety concerns with these precursors?
At studied doses, all three appear well-tolerated in short-term human studies. Long-term safety (years to decades of administration) is not established for any of them. NAD+ injections occasionally produce facial flushing and brief chest tightness; oral NR and NMN are generally well-tolerated.
Should I take NAD+ if I am healthy?
The honest answer is uncertain. For a healthy adult under 50 with no specific clinical concern, the evidence base does not support strong recommendation. For adults 50+ with subjective fatigue, mild metabolic dysfunction, or post-acute recovery needs, NAD+ may have a useful role. For specific clinical indications (chronic fatigue syndrome research, post-COVID recovery, neurodegenerative disease research), targeted protocols are being studied.
Next Step
Talk to a TelePeptide Clinician
A licensed clinician will review your goals and recommend the right protocol — peptide wellness, recomposition, or supervised weight loss. No insurance, no waiting room.
TelePeptide offers direct-pay telehealth services. All medications are compounded by licensed 503A pharmacies. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA. Compounded medications are not FDA-approved.